Pietro Maffei

SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations

L. Busetto, F. Dassie, S. Bettini, 2023, Diabetes, metabolic syndrome and obesity : targets and therapy.